loadpatents
name:-0.53601288795471
name:-0.088545799255371
name:-0.0081589221954346
Signaevsky; Maxim Patent Filings

Signaevsky; Maxim

Patent Applications and Registrations

Patent applications and USPTO patent grants for Signaevsky; Maxim.The latest application filed is for "bi-directional neuron-electronic device interface structures".

Company Profile
5.25.23
  • Signaevsky; Maxim - Brooklyn NY
  • Signaevsky; Maxim - Brookyn NY
  • Signaevsky; Maxim - Brookyln NY
  • Signaevsky; Maxim - Vancouver CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Photosensitive multilayered composite material suitable for eye implants
Grant 10,845,667 - Signaevsky , et al. November 24, 2
2020-11-24
Bi-directional Neuron-electronic Device Interface Structures
App 20200214583 - Signaevsky; Maxim ;   et al.
2020-07-09
Novel Multilayered Composite Material Utilizing Quantum Dot Based Photovoltaic Effect For Bi-directional Brain-computer Interfac
App 20200161485 - Signaevsky; Maxim ;   et al.
2020-05-21
Bi-directional neuron-electronic device interface structures
Grant 10,602,939 - Signaevsky , et al.
2020-03-31
Photosensitive Multilayered Composite Material Suitable For Eye Implants
App 20190369454 - Signaevsky; Maxim ;   et al.
2019-12-05
Bi-directional Neuron-electronic Device Interface Structures
App 20180214042 - Signaevsky; Maxim ;   et al.
2018-08-02
Compositions and methods for treatment of prostate and other cancers
Grant 9,580,712 - Gleave , et al. February 28, 2
2017-02-28
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20160326527 - Gleave; Martin E. ;   et al.
2016-11-10
RNAi probes targeting cancer-related proteins
Grant 9,487,777 - Gleave , et al. November 8, 2
2016-11-08
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20160002630 - Gleave; Martin E. ;   et al.
2016-01-07
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20150232843 - Gleave; Martin E. ;   et al.
2015-08-20
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 9,101,646 - Gleave , et al. August 11, 2
2015-08-11
Compositions and methods for treatment of prostate and other cancers
Grant 9,085,769 - Gleave , et al. July 21, 2
2015-07-21
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20140315978 - Gleave; Martin E. ;   et al.
2014-10-23
Compositions and methods for treatment of prostate and other cancers
Grant 8,772,470 - Gleave , et al. July 8, 2
2014-07-08
RNAi probes targeting cancer-related proteins
Grant 8,759,308 - Gleave , et al. June 24, 2
2014-06-24
Compositions and methods for treatment of prostate and other cancers
Grant 8,722,872 - Gleave , et al. May 13, 2
2014-05-13
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 8,580,761 - Gleave , et al. November 12, 2
2013-11-12
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20130096180 - Gleave; Martin ;   et al.
2013-04-18
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 8,389,491 - Gleave , et al. March 5, 2
2013-03-05
RNAi probes targeting cancer-related proteins
Grant 8,252,918 - Gleave , et al. August 28, 2
2012-08-28
RNAi Probes Targeting Cancer-Related Proteins
App 20120202873 - Gleave; Martin ;   et al.
2012-08-09
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20120077861 - Gleave; Martin ;   et al.
2012-03-29
RNAi probes targeting cancer-related proteins
Grant 7,964,717 - Gleave , et al. June 21, 2
2011-06-21
Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
Grant 7,928,082 - Gleave , et al. April 19, 2
2011-04-19
RNAi Probes Targeting Cancer-Related Proteins
App 20110009472 - Gleave; Martin ;   et al.
2011-01-13
Compositions and methods for treatment of prostate and other cancers
Grant 7,847,091 - Gleave , et al. December 7, 2
2010-12-07
RNAi probes targeting cancer-related proteins
Grant 7,820,635 - Gleave , et al. October 26, 2
2010-10-26
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20100267808 - Gleave; Martin ;   et al.
2010-10-21
Compositions and methods for treatment of prostate and other cancers
Grant 7,723,312 - Gleave , et al. May 25, 2
2010-05-25
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20090292008 - Gleave; Martin E. ;   et al.
2009-11-26
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20090221678 - Gleave; Martin E. ;   et al.
2009-09-03
Compositions and methods for treatment of prostate and other cancers
Grant 7,550,580 - Gleave , et al. June 23, 2
2009-06-23
RNAi Probes Targeting Cancer-Related Proteins
App 20080274996 - Gleave; Martin ;   et al.
2008-11-06
Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
App 20080261912 - Gleave; Martin E. ;   et al.
2008-10-23
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20060276424 - Gleave; Martin E. ;   et al.
2006-12-07
Compositions and methods for treatment of prostate and other cancers
Grant 7,101,991 - Gleave , et al. September 5, 2
2006-09-05
RNAi probes targeting cancer-related proteins
App 20060178329 - Gleave; Martin ;   et al.
2006-08-10
Compositions and methods for treatment of prostate and other cancers
App 20060040886 - Gleave; Martin E. ;   et al.
2006-02-23
Compositions and Methods for Treatment of Prostate and Other Cancers
App 20040127441 - Gleave, Martin ;   et al.
2004-07-01
RNAi probes targeting cancer-related proteins
App 20040096882 - Gleave, Martin ;   et al.
2004-05-20
Bispecific antisense olignucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
App 20030158143 - Gleave, Martin ;   et al.
2003-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed